Posted by Jeff Daas on Mar 10th, 2010 | No Comments
Alison Walker, MD, has been selected to receive the ASH-AMFDP Award, and will begin her research in acute myeloid leukemia in July of this year…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati (UC) has concluded…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
The Washington Post on Tuesday published a list of questions and answers from a Consumer Reports review of the safety and efficacy of Merck’s human papillomavirus vaccine, Gardasil…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
mtm laboratories, a privately held diagnostics company announced the launch of CINtec® PLUS, the company’s next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
TechniScan, Inc. (OTC Bulletin Board: TSNI) (“TechniScan” or the “Company”), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
TechniScan, Inc. (OTC Bulletin Board: TSNI) (“TechniScan” or the “Company”), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma…
Read Full Article
Posted by Jeff Daas on Mar 10th, 2010 | No Comments
The Side-Out Foundation, which pairs volleyball enthusiasts with breast cancer researchers, is sponsoring a new clinical trial for up to 25 patients with advanced breast cancer. TGen Drug Development (TD2) will manage this pilot study for the Side-Out Foundation at two locations: TGen Clinical Research Services (TCRS) at Scottsdale Healthcare in Scottsdale, Ariz…
Read Full Article